Medality Medical™ LLC Receives FDA Investigational Device Exemption Approval for Reversal of Type 2 Diabetes Clinical Trial

Press/Media: Press / Media

PeriodFeb 14 2019

Media coverage

7

Media coverage

  • TitleMedality Medical™ LLC Receives FDA Investigational Device Exemption Approval for Reversal of Type 2 Diabetes Clinical Trial
    Media name/outletMorningstar.com
    CountryUnited States
    Date2/14/19
    PersonsRichard M Peterson, Ralph A Defronzo
  • TitleMedality Medical™ LLC Receives FDA Investigational Device Exemption Approval for Reversal of Type 2 Diabetes Clinical Trial
    Media name/outletGlobal Banking & Finance Review
    CountryUnited Kingdom
    Date2/14/19
    PersonsRichard M Peterson, Ralph A Defronzo
  • TitleMedality Medical™ LLC Receives FDA Investigational Device Exemption Approval for Reversal of Type 2 Diabetes Clinical Trial
    Media name/outletMarketScreener.com
    CountryUnited States
    Date2/14/19
    PersonsRichard M Peterson, Ralph A Defronzo
  • TitleMedality Medical™ LLC Receives FDA Investigational Device Exemption Approval for Reversal of Type 2 Diabetes Clinical Trial
    Media name/outletConsumer Electronics Net
    CountryUnited States
    Date2/14/19
    PersonsRichard M Peterson, Ralph A Defronzo
  • TitleMedality Medical™ LLC Receives FDA Investigational Device Exemption Approval for Reversal of Type 2 Diabetes Clinical Trial
    Media name/outletSpoke.com
    CountryUnited States
    Date2/14/19
    PersonsRichard M Peterson, Ralph A Defronzo
  • TitleMedality Medical™ LLC Receives FDA Investigational Device Exemption Approval for Reversal of Type 2 Diabetes Clinical Trial
    Media name/outletBusiness Wire
    CountryUnited States
    Date2/14/19
    PersonsRichard M Peterson, Ralph A Defronzo
  • TitleMedality Medical™ LLC Receives FDA Investigational Device Exemption Approval for Reversal of Type 2 Diabetes Clinical Trial
    Media name/outletCIT
    CountryUnited States
    Date2/14/19
    PersonsRichard M Peterson, Ralph A Defronzo